Laura P. Serwer
Affiliations: | Neurological Surgery | University of California, San Francisco, San Francisco, CA |
Google:
"Laura Serwer"Mean distance: 42746.4
Parents
Sign in to add mentor| C. David James | grad student | 2011 | UCSF | |
| (Investigating the Use of Protein and Liposomal Therapeutics for the Treatment of Glioblastoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Krtolica A, Moan NL, Getz J, et al. (2015) Abstract 3003: OMX-4.80P, a novel H-NOX oxygen carrier that oxygenates hypoxic tumors in multiple tumor models and canine cancer patients, downregulates HIF-1 pathway and increases response to radiation therapy leading to cures Cancer Research. 75: 3003-3003 |
| Serwer L, Le Moan N, Regan M, et al. (2015) NIMG-45REAL-TIME PET IMAGING DEMONSTRATES TUMOR ACCUMULATION AND OXYGENATION BY OMX-4.80P, AN OXYGEN CARRIER ENGINEERED FOR THE TREATMENT OF GLIOBLASTOMA Neuro-Oncology. 17: v164.1-v164 |
| Leung P, Le Moan N, Getz J, et al. (2015) ATPS-49RESULTS OF A PHASE 0 CLINICAL TRIAL IN CANINE BRAIN CANCER EVALUATING SAFETY AND ACTIVITY OF OMX-4.80P, A PROTEIN OXYGEN CARRIER IND CANDIDATE FOR TREATMENT OF GLIOBLASTOMA Neuro-Oncology. 17: v29.1-v29 |
| Le Moan N, Getz J, Ng S, et al. (2014) ET-32 * HYPOXIA REDUCTION IN INTRACRANIAL GLIOBLASTOMA MODELS BY OMX-4.80P, A PEGylated ENGINEERED H-NOX OXYGEN CARRIER THAT IS LONG-LASTING IN CIRCULATION AND SAFE Neuro-Oncology. 16: v86-v86 |
| Krtolica A, Le Moan N, Getz J, et al. (2014) ET-31 * RADIOSENSITIZATION BY OMX-4.80P, A PEGylated H-NOX OXYGEN CARRIER THAT PENETRATES AND OXYGENATES HYPOXIC TUMORS, IN PRECLINICAL MODELS OF GLIOBLASTOMA AND OTHER HYPOXIC CANCERS Neuro-Oncology. 16: v86-v86 |
| Krtolica A, Le Moan N, Serwer L, et al. (2014) O2.04 * TREATMENT WITH OMX-4.80, A TUMOR-PENETRATING TUNABLE OXYGEN CARRIER, REDUCES TUMOR HYPOXIA AND DRAMATICALLY ENHANCES RADIATION THERAPY IN INTRACRANIAL MODELS OF GLIOBLASTOMA Neuro-Oncology. 16: ii3-ii4 |
| Weng KC, Hashizume R, Noble CO, et al. (2013) Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models. Nanomedicine (London, England). 8: 1913-25 |
| Aaberg-Jessen C, Fogh L, Halle B, et al. (2013) EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 15: iii37-iii61 |
| Serwer LP, James CD. (2012) Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations. Advanced Drug Delivery Reviews. 64: 590-7 |
| Serwer LP, Noble CO, Michaud K, et al. (2011) Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts. Neuro-Oncology. 13: 1288-95 |